Skip to main content
. 2019 Oct 9;10:1158. doi: 10.3389/fphar.2019.01158

Figure 1.

Figure 1

Antiplatelet effect of IPA with addition of TXA2 (A) and ADP. (B) TXA2, 1 mmol/L; ADP, 20 μmol/L; IPA, inhibition of platelet aggregation; *P < 0.05.